Management Sciences for Health to Help Facilitate Roll out of New Drugs in Low and Middle Income Countries
Management Sciences for Health (MSH) announced today that it has been awarded a grant from the World Bank to advance health systems strengthening against non-communicable diseases (NCDs) in low- and middle-income countries (LMICs). The project will be led by MSH and joined by partners Research Triangle Institute (RTI) International and Global Health Insights (GLOHI).
“The ultimate goal of this work is to enable sustainable access to innovation and promote better resource allocation for non-communicable diseases, such as cardiovascular disease, cancer, and diabetes,” said Douglas Keene, MSH’s Vice President, Pharmaceuticals and Health Technologies Group. “Since the burden of non-communicable diseases in low- and middle-income countries is substantial and growing, we are very much looking forward to helping bring more lifesaving medicines to some of the world’s most vulnerable people.”
The project aims to inform policy makers in LMICs about potential institutional arrangements and policy solutions between manufacturers and payers for sharing the financial risk surrounding the introduction of newly patented medicines.
The project, titled Multi-Stakeholder Platform for Knowledge Sharing on Access Solutions for Innovative Patented Medicine, starts in December 2017 and ends next September.